T. Parkkari

A. Poso, M. Lahtela-Kakkonen, T. Nevalainen, 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Synthesis, biological activity and molecular modeling of new biphenylic carboxamides as potent and selective CB2 receptor ligands.

Ettore Novellino, Luciana Marinelli, Marco Macchia, 2015, European journal of medicinal chemistry.

CB2 receptor as a potential target in age-related diseases

A. Salminen, A. Kauppinen, T. Nevalainen, 2014 .

Potent and selective N-(4-sulfamoylphenyl)thiourea-based GPR55 agonists.

A. Irving, A. Poso, T. Laitinen, 2016, European journal of medicinal chemistry.

In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)

J. Laitinen, T. Nevalainen, M. Lehtonen, 2016, The Journal of Pharmacology and Experimental Therapeutics.

Loratadine analogues as MAGL inhibitors.

Tuomo Laitinen, T. Laitinen, J. Laitinen, 2015, Bioorganic & medicinal chemistry letters.

Alpha-methylated derivatives of 2-arachidonoyl glycerol: synthesis, CB1 receptor activity, and enzymatic stability.

J. Laitinen, T. Nevalainen, S. Saario, 2006, Bioorganic & medicinal chemistry letters.

Synthesis and CB1 receptor activities of dimethylheptyl derivatives of 2-arachidonoyl glycerol (2-AG) and 2-arachidonyl glyceryl ether (2-AGE).

A. Poso, J. Laitinen, T. Nevalainen, 2006, Bioorganic & medicinal chemistry.

Discovery of novel cannabinoid receptor ligands by a virtual screening approach: further development of 2,4,6-trisubstituted 1,3,5-triazines as CB2 agonists.

Antti Poso, Tuomo Laitinen, Tuomo Kalliokoski, 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Comparative molecular field analysis and molecular dynamics studies of α/β hydrolase domain containing 6 (ABHD6) inhibitors

Antti Poso, Tuomo Laitinen, Agnieszka A. Kaczor, 2015, Journal of Molecular Modeling.

α‐Methylated Derivatives of 2‐Arachidonoyl Glycerol: Synthesis, CB1 Receptor Activity, and Enzymatic Stability.

J. Laitinen, T. Nevalainen, S. Saario, 2006 .

Mutation of Cys 242 of Human Monoacylglycerol Lipase Disrupts Balanced Hydrolysis of 1-and 2-Monoacylglycerols and Selectively Impairs Inhibitor Potency s

A. Poso, T. Laitinen, J. Laitinen, 2014 .

Electrostatic tuning of cellular excitability.

Fredrik Elinder, F. Elinder, Sara I Börjesson, 2010, Biophysical journal.

Synthesis, in vitro and in vivo evaluation of 1,3,5-triazines as cannabinoid CB2 receptor agonists.

A. Poso, M. Sarparanta, A. Airaksinen, 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Improved synthesis of [18F] fallypride and characterization of a Huntington’s disease mouse model, zQ175DN KI, using longitudinal PET imaging of D2/D3 receptors

J. Wityak, A. Airaksinen, L. Park, 2019, EJNMMI Radiopharmacy and Chemistry.

1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor.

A. Malfitano, V. Di Marzo, A. Ligresti, 2014, European journal of medicinal chemistry.

Global Rhes knockout in the Q175 Huntington’s disease mouse model

D. Marchionini, T. Bragge, N. Shahani, 2021, PloS one.

Polyunsaturated fatty acid analogs act antiarrhythmically on the cardiac IKs channel

Fredrik Elinder, Nicole Schmitt, F. Elinder, 2015, Proceedings of the National Academy of Sciences.

Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).

T. Laitinen, J. Laitinen, T. Nevalainen, 2014, Bioorganic & medicinal chemistry.

CB2 receptor activation causes an ERK1/2-dependent inflammatory response in human RPE cells

G. Petrovski, A. Kauppinen, K. Kaarniranta, 2017, Scientific Reports.

Impaired Performance of the Q175 Mouse Model of Huntington’s Disease in the Touch Screen Paired Associates Learning Task

R. Cachope, M. Kopanitsa, L. Park, 2018, Front. Behav. Neurosci..

3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data.

Antti Poso, Tomi Järvinen, Maija Lahtela-Kakkonen, 2006, Journal of medicinal chemistry.